nodes	percent_of_prediction	percent_of_DWPC	metapath
Loxapine—DRD2—nicotine dependence	0.641	1	CbGaD
Loxapine—Polydipsia—Varenicline—nicotine dependence	0.0111	0.111	CcSEcCtD
Loxapine—Throat irritation—Varenicline—nicotine dependence	0.0068	0.0684	CcSEcCtD
Loxapine—Extrapyramidal symptoms—Varenicline—nicotine dependence	0.00662	0.0665	CcSEcCtD
Loxapine—Extrapyramidal disorder—Varenicline—nicotine dependence	0.00456	0.0458	CcSEcCtD
Loxapine—HTR5A—brain—nicotine dependence	0.00447	0.0684	CbGeAlD
Loxapine—Chest discomfort—Varenicline—nicotine dependence	0.00388	0.039	CcSEcCtD
Loxapine—Dysarthria—Varenicline—nicotine dependence	0.00363	0.0365	CcSEcCtD
Loxapine—Salivary hypersecretion—Varenicline—nicotine dependence	0.00333	0.0335	CcSEcCtD
Loxapine—Dry eye—Varenicline—nicotine dependence	0.00317	0.0319	CcSEcCtD
Loxapine—HRH2—cardiovascular system—nicotine dependence	0.00279	0.0427	CbGeAlD
Loxapine—Cerebrovascular accident—Varenicline—nicotine dependence	0.00254	0.0256	CcSEcCtD
Loxapine—Psychotic disorder—Varenicline—nicotine dependence	0.00243	0.0245	CcSEcCtD
Loxapine—Urinary retention—Varenicline—nicotine dependence	0.00237	0.0238	CcSEcCtD
Loxapine—DRD4—brain—nicotine dependence	0.00222	0.0338	CbGeAlD
Loxapine—Dysphagia—Varenicline—nicotine dependence	0.00215	0.0217	CcSEcCtD
Loxapine—Photosensitivity reaction—Varenicline—nicotine dependence	0.00197	0.0198	CcSEcCtD
Loxapine—Weight increased—Varenicline—nicotine dependence	0.00196	0.0197	CcSEcCtD
Loxapine—HTR1E—brain—nicotine dependence	0.00191	0.0292	CbGeAlD
Loxapine—HTR1B—cardiovascular system—nicotine dependence	0.00184	0.0281	CbGeAlD
Loxapine—CHRM2—cardiovascular system—nicotine dependence	0.00183	0.028	CbGeAlD
Loxapine—HTR1D—cardiovascular system—nicotine dependence	0.00178	0.0272	CbGeAlD
Loxapine—DRD1—midbrain—nicotine dependence	0.00177	0.0271	CbGeAlD
Loxapine—ADRB1—cardiovascular system—nicotine dependence	0.00173	0.0265	CbGeAlD
Loxapine—Hypoaesthesia—Varenicline—nicotine dependence	0.00172	0.0172	CcSEcCtD
Loxapine—CHRM4—brain—nicotine dependence	0.00167	0.0256	CbGeAlD
Loxapine—CHRM1—cardiovascular system—nicotine dependence	0.00167	0.0255	CbGeAlD
Loxapine—Angiopathy—Varenicline—nicotine dependence	0.00156	0.0157	CcSEcCtD
Loxapine—DRD3—brain—nicotine dependence	0.00156	0.0238	CbGeAlD
Loxapine—Mediastinal disorder—Varenicline—nicotine dependence	0.00155	0.0156	CcSEcCtD
Loxapine—HTR6—brain—nicotine dependence	0.0015	0.0229	CbGeAlD
Loxapine—HTR1A—cardiovascular system—nicotine dependence	0.00149	0.0227	CbGeAlD
Loxapine—Dysgeusia—Varenicline—nicotine dependence	0.00147	0.0148	CcSEcCtD
Loxapine—DRD5—brain—nicotine dependence	0.00146	0.0223	CbGeAlD
Loxapine—Muscle spasms—Varenicline—nicotine dependence	0.00144	0.0145	CcSEcCtD
Loxapine—HTR1B—midbrain—nicotine dependence	0.00144	0.022	CbGeAlD
Loxapine—SLC6A3—midbrain—nicotine dependence	0.00143	0.0218	CbGeAlD
Loxapine—HTR7—cardiovascular system—nicotine dependence	0.00142	0.0217	CbGeAlD
Loxapine—Vision blurred—Varenicline—nicotine dependence	0.00141	0.0142	CcSEcCtD
Loxapine—Tremor—Varenicline—nicotine dependence	0.00141	0.0141	CcSEcCtD
Loxapine—HTR1D—midbrain—nicotine dependence	0.00139	0.0213	CbGeAlD
Loxapine—Agitation—Varenicline—nicotine dependence	0.00138	0.0139	CcSEcCtD
Loxapine—HTR2C—midbrain—nicotine dependence	0.00138	0.0211	CbGeAlD
Loxapine—HRH2—brain—nicotine dependence	0.00137	0.0209	CbGeAlD
Loxapine—ADRA1A—cardiovascular system—nicotine dependence	0.00137	0.0209	CbGeAlD
Loxapine—Syncope—Varenicline—nicotine dependence	0.00135	0.0135	CcSEcCtD
Loxapine—Loss of consciousness—Varenicline—nicotine dependence	0.00132	0.0133	CcSEcCtD
Loxapine—Cough—Varenicline—nicotine dependence	0.00131	0.0132	CcSEcCtD
Loxapine—CHRM5—brain—nicotine dependence	0.00131	0.02	CbGeAlD
Loxapine—SLC6A4—midbrain—nicotine dependence	0.00131	0.02	CbGeAlD
Loxapine—Convulsion—Varenicline—nicotine dependence	0.0013	0.0131	CcSEcCtD
Loxapine—Hypertension—Varenicline—nicotine dependence	0.0013	0.013	CcSEcCtD
Loxapine—Chest pain—Varenicline—nicotine dependence	0.00128	0.0128	CcSEcCtD
Loxapine—Dry mouth—Varenicline—nicotine dependence	0.00125	0.0126	CcSEcCtD
Loxapine—Oedema—Varenicline—nicotine dependence	0.00122	0.0123	CcSEcCtD
Loxapine—Shock—Varenicline—nicotine dependence	0.0012	0.0121	CcSEcCtD
Loxapine—Nervous system disorder—Varenicline—nicotine dependence	0.0012	0.0121	CcSEcCtD
Loxapine—Thrombocytopenia—Varenicline—nicotine dependence	0.0012	0.0121	CcSEcCtD
Loxapine—ADRA1B—brain—nicotine dependence	0.0012	0.0183	CbGeAlD
Loxapine—Tachycardia—Varenicline—nicotine dependence	0.0012	0.012	CcSEcCtD
Loxapine—HTR1A—midbrain—nicotine dependence	0.00116	0.0177	CbGeAlD
Loxapine—Hypotension—Varenicline—nicotine dependence	0.00114	0.0115	CcSEcCtD
Loxapine—DRD1—brain—nicotine dependence	0.00112	0.017	CbGeAlD
Loxapine—HTR7—midbrain—nicotine dependence	0.00111	0.0169	CbGeAlD
Loxapine—Insomnia—Varenicline—nicotine dependence	0.00111	0.0111	CcSEcCtD
Loxapine—Asenapine—DRD2—nicotine dependence	0.0011	0.165	CrCbGaD
Loxapine—Dyspnoea—Varenicline—nicotine dependence	0.00109	0.011	CcSEcCtD
Loxapine—Somnolence—Varenicline—nicotine dependence	0.00109	0.0109	CcSEcCtD
Loxapine—HTR3A—brain—nicotine dependence	0.00108	0.0164	CbGeAlD
Loxapine—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00106	0.0106	CcSEcCtD
Loxapine—Fatigue—Varenicline—nicotine dependence	0.00106	0.0106	CcSEcCtD
Loxapine—DRD2—midbrain—nicotine dependence	0.00105	0.016	CbGeAlD
Loxapine—Constipation—Varenicline—nicotine dependence	0.00105	0.0105	CcSEcCtD
Loxapine—Temazepam—GABRA4—nicotine dependence	0.00103	0.155	CrCbGaD
Loxapine—ADRA2C—midbrain—nicotine dependence	0.00102	0.0156	CbGeAlD
Loxapine—Feeling abnormal—Varenicline—nicotine dependence	0.00101	0.0101	CcSEcCtD
Loxapine—HTR1B—brain—nicotine dependence	0.000903	0.0138	CbGeAlD
Loxapine—Hypersensitivity—Varenicline—nicotine dependence	0.000902	0.00907	CcSEcCtD
Loxapine—CHRM2—brain—nicotine dependence	0.000899	0.0137	CbGeAlD
Loxapine—SLC6A3—brain—nicotine dependence	0.000896	0.0137	CbGeAlD
Loxapine—HTR2A—cardiovascular system—nicotine dependence	0.000885	0.0135	CbGeAlD
Loxapine—Asthenia—Varenicline—nicotine dependence	0.000879	0.00884	CcSEcCtD
Loxapine—HTR1D—brain—nicotine dependence	0.000875	0.0134	CbGeAlD
Loxapine—Pruritus—Varenicline—nicotine dependence	0.000866	0.00871	CcSEcCtD
Loxapine—HTR2C—brain—nicotine dependence	0.000866	0.0132	CbGeAlD
Loxapine—ADRB1—brain—nicotine dependence	0.00085	0.013	CbGeAlD
Loxapine—SLC6A4—brain—nicotine dependence	0.000821	0.0125	CbGeAlD
Loxapine—CHRM1—brain—nicotine dependence	0.000818	0.0125	CbGeAlD
Loxapine—ADRA2A—midbrain—nicotine dependence	0.000813	0.0124	CbGeAlD
Loxapine—Dizziness—Varenicline—nicotine dependence	0.00081	0.00814	CcSEcCtD
Loxapine—Vomiting—Varenicline—nicotine dependence	0.000779	0.00783	CcSEcCtD
Loxapine—Rash—Varenicline—nicotine dependence	0.000772	0.00777	CcSEcCtD
Loxapine—Dermatitis—Varenicline—nicotine dependence	0.000771	0.00776	CcSEcCtD
Loxapine—Headache—Varenicline—nicotine dependence	0.000767	0.00772	CcSEcCtD
Loxapine—CHRM3—brain—nicotine dependence	0.000732	0.0112	CbGeAlD
Loxapine—HTR1A—brain—nicotine dependence	0.000729	0.0111	CbGeAlD
Loxapine—Nausea—Varenicline—nicotine dependence	0.000727	0.00732	CcSEcCtD
Loxapine—SLC6A2—brain—nicotine dependence	0.000723	0.011	CbGeAlD
Loxapine—HTR7—brain—nicotine dependence	0.000697	0.0106	CbGeAlD
Loxapine—HTR2A—midbrain—nicotine dependence	0.000691	0.0106	CbGeAlD
Loxapine—ADRA1A—brain—nicotine dependence	0.000672	0.0103	CbGeAlD
Loxapine—DRD2—brain—nicotine dependence	0.000659	0.0101	CbGeAlD
Loxapine—ADRA2C—brain—nicotine dependence	0.00064	0.00978	CbGeAlD
Loxapine—Zuclopenthixol—DRD2—nicotine dependence	0.00064	0.0964	CrCbGaD
Loxapine—Cyproheptadine—DRD2—nicotine dependence	0.000629	0.0948	CrCbGaD
Loxapine—Olanzapine—DRD2—nicotine dependence	0.000609	0.0918	CrCbGaD
Loxapine—Thiothixene—DRD2—nicotine dependence	0.000552	0.0831	CrCbGaD
Loxapine—Prochlorperazine—DRD2—nicotine dependence	0.000527	0.0794	CrCbGaD
Loxapine—HRH1—brain—nicotine dependence	0.00052	0.00795	CbGeAlD
Loxapine—ADRA2A—brain—nicotine dependence	0.000511	0.00781	CbGeAlD
Loxapine—Amoxapine—DRD2—nicotine dependence	0.000485	0.0731	CrCbGaD
Loxapine—HTR2A—brain—nicotine dependence	0.000434	0.00664	CbGeAlD
Loxapine—Trifluoperazine—DRD2—nicotine dependence	0.000381	0.0574	CrCbGaD
Loxapine—Quetiapine—DRD2—nicotine dependence	0.00037	0.0557	CrCbGaD
Loxapine—Clozapine—DRD2—nicotine dependence	0.000318	0.0479	CrCbGaD
Loxapine—HTR6—Signaling by GPCR—OPRM1—nicotine dependence	7.3e-05	0.000389	CbGpPWpGaD
Loxapine—HTR7—Signaling by GPCR—OPRM1—nicotine dependence	7.3e-05	0.000388	CbGpPWpGaD
Loxapine—CHRM5—GPCR downstream signaling—OPRM1—nicotine dependence	7.27e-05	0.000387	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—FGD1—nicotine dependence	7.26e-05	0.000386	CbGpPWpGaD
Loxapine—HRH4—Signaling Pathways—OPRM1—nicotine dependence	7.26e-05	0.000386	CbGpPWpGaD
Loxapine—ADRA1B—GPCR ligand binding—DRD2—nicotine dependence	7.25e-05	0.000386	CbGpPWpGaD
Loxapine—HTR1D—Signaling by GPCR—OPRM1—nicotine dependence	7.25e-05	0.000386	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—TAS2R16—nicotine dependence	7.22e-05	0.000384	CbGpPWpGaD
Loxapine—HTR1B—Signaling by GPCR—OPRM1—nicotine dependence	7.1e-05	0.000378	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—AKR1B10—nicotine dependence	7.09e-05	0.000378	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—AKR1B10—nicotine dependence	7.09e-05	0.000377	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—AKR1B10—nicotine dependence	7.04e-05	0.000375	CbGpPWpGaD
Loxapine—HTR1E—Signaling Pathways—WASF1—nicotine dependence	7.02e-05	0.000373	CbGpPWpGaD
Loxapine—DRD4—Signaling by GPCR—OPRM1—nicotine dependence	6.98e-05	0.000372	CbGpPWpGaD
Loxapine—DRD1—GPCR downstream signaling—OPRM1—nicotine dependence	6.92e-05	0.000369	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—FGD1—nicotine dependence	6.91e-05	0.000368	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—AKR1B10—nicotine dependence	6.89e-05	0.000367	CbGpPWpGaD
Loxapine—CHRM4—Signaling by GPCR—OPRM1—nicotine dependence	6.89e-05	0.000367	CbGpPWpGaD
Loxapine—HRH2—Signaling by GPCR—DRD2—nicotine dependence	6.89e-05	0.000367	CbGpPWpGaD
Loxapine—DRD5—Signaling by GPCR—DRD2—nicotine dependence	6.84e-05	0.000364	CbGpPWpGaD
Loxapine—DRD3—GPCR downstream signaling—OPRM1—nicotine dependence	6.83e-05	0.000364	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—FGD1—nicotine dependence	6.82e-05	0.000363	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—AKR1B10—nicotine dependence	6.78e-05	0.000361	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—AKR1B10—nicotine dependence	6.69e-05	0.000356	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—TAS2R16—nicotine dependence	6.65e-05	0.000354	CbGpPWpGaD
Loxapine—CHRM5—Signaling by GPCR—OPRM1—nicotine dependence	6.6e-05	0.000351	CbGpPWpGaD
Loxapine—HTR2A—GPCR ligand binding—DRD2—nicotine dependence	6.58e-05	0.00035	CbGpPWpGaD
Loxapine—HRH1—GPCR ligand binding—DRD2—nicotine dependence	6.57e-05	0.00035	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—TAS2R16—nicotine dependence	6.55e-05	0.000348	CbGpPWpGaD
Loxapine—CHRM1—GPCR ligand binding—DRD2—nicotine dependence	6.55e-05	0.000348	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—TAS2R16—nicotine dependence	6.53e-05	0.000348	CbGpPWpGaD
Loxapine—CHRM3—GPCR ligand binding—DRD2—nicotine dependence	6.52e-05	0.000347	CbGpPWpGaD
Loxapine—HRH2—Signaling Pathways—WASF2—nicotine dependence	6.52e-05	0.000347	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—TAS2R16—nicotine dependence	6.51e-05	0.000347	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—TAS2R16—nicotine dependence	6.49e-05	0.000345	CbGpPWpGaD
Loxapine—DRD5—Signaling Pathways—WASF2—nicotine dependence	6.48e-05	0.000345	CbGpPWpGaD
Loxapine—CHRM2—GPCR ligand binding—DRD2—nicotine dependence	6.46e-05	0.000344	CbGpPWpGaD
Loxapine—ADRA1A—GPCR ligand binding—DRD2—nicotine dependence	6.44e-05	0.000343	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—TAS2R16—nicotine dependence	6.43e-05	0.000342	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—AKR1B10—nicotine dependence	6.41e-05	0.000341	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—TAS2R16—nicotine dependence	6.41e-05	0.000341	CbGpPWpGaD
Loxapine—HTR1E—Signaling Pathways—OPRM1—nicotine dependence	6.32e-05	0.000336	CbGpPWpGaD
Loxapine—DRD1—Signaling by GPCR—OPRM1—nicotine dependence	6.29e-05	0.000335	CbGpPWpGaD
Loxapine—HRH2—Signaling Pathways—WASF1—nicotine dependence	6.25e-05	0.000333	CbGpPWpGaD
Loxapine—ADRB1—GPCR downstream signaling—OPRM1—nicotine dependence	6.22e-05	0.000331	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—FGD1—nicotine dependence	6.22e-05	0.000331	CbGpPWpGaD
Loxapine—DRD5—Signaling Pathways—WASF1—nicotine dependence	6.21e-05	0.000331	CbGpPWpGaD
Loxapine—DRD3—Signaling by GPCR—OPRM1—nicotine dependence	6.2e-05	0.00033	CbGpPWpGaD
Loxapine—ADRA2B—GPCR downstream signaling—OPRM1—nicotine dependence	6.17e-05	0.000328	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—FGD1—nicotine dependence	6.16e-05	0.000328	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—AKR1B10—nicotine dependence	6.11e-05	0.000325	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—AKR1B10—nicotine dependence	6.03e-05	0.000321	CbGpPWpGaD
Loxapine—ADRA2A—GPCR ligand binding—DRD2—nicotine dependence	5.99e-05	0.000319	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—TAS2R16—nicotine dependence	5.96e-05	0.000317	CbGpPWpGaD
Loxapine—HTR1A—GPCR downstream signaling—OPRM1—nicotine dependence	5.95e-05	0.000317	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—FGD1—nicotine dependence	5.95e-05	0.000316	CbGpPWpGaD
Loxapine—HTR2C—GPCR downstream signaling—OPRM1—nicotine dependence	5.92e-05	0.000315	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—FGD1—nicotine dependence	5.91e-05	0.000315	CbGpPWpGaD
Loxapine—HTR6—GPCR downstream signaling—DRD2—nicotine dependence	5.82e-05	0.00031	CbGpPWpGaD
Loxapine—HTR7—GPCR downstream signaling—DRD2—nicotine dependence	5.81e-05	0.000309	CbGpPWpGaD
Loxapine—HTR1D—GPCR downstream signaling—DRD2—nicotine dependence	5.77e-05	0.000307	CbGpPWpGaD
Loxapine—ADRA2C—GPCR downstream signaling—OPRM1—nicotine dependence	5.76e-05	0.000307	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—FGD1—nicotine dependence	5.75e-05	0.000306	CbGpPWpGaD
Loxapine—ADRA1B—GPCR downstream signaling—OPRM1—nicotine dependence	5.67e-05	0.000302	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—FGD1—nicotine dependence	5.66e-05	0.000301	CbGpPWpGaD
Loxapine—ADRB1—Signaling by GPCR—OPRM1—nicotine dependence	5.65e-05	0.000301	CbGpPWpGaD
Loxapine—HTR1B—GPCR downstream signaling—DRD2—nicotine dependence	5.65e-05	0.000301	CbGpPWpGaD
Loxapine—ADRA2C—Metabolism—CYP2A7—nicotine dependence	5.65e-05	0.000301	CbGpPWpGaD
Loxapine—HRH2—Signaling Pathways—OPRM1—nicotine dependence	5.63e-05	0.000299	CbGpPWpGaD
Loxapine—ADRA2B—Signaling by GPCR—OPRM1—nicotine dependence	5.6e-05	0.000298	CbGpPWpGaD
Loxapine—DRD5—Signaling Pathways—OPRM1—nicotine dependence	5.59e-05	0.000298	CbGpPWpGaD
Loxapine—DRD4—GPCR downstream signaling—DRD2—nicotine dependence	5.56e-05	0.000296	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—AKR1B10—nicotine dependence	5.49e-05	0.000292	CbGpPWpGaD
Loxapine—CHRM4—GPCR downstream signaling—DRD2—nicotine dependence	5.49e-05	0.000292	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—AKR1B10—nicotine dependence	5.44e-05	0.00029	CbGpPWpGaD
Loxapine—HTR1A—Signaling by GPCR—OPRM1—nicotine dependence	5.41e-05	0.000288	CbGpPWpGaD
Loxapine—HTR2C—Signaling by GPCR—OPRM1—nicotine dependence	5.38e-05	0.000286	CbGpPWpGaD
Loxapine—HTR6—Signaling by GPCR—DRD2—nicotine dependence	5.28e-05	0.000281	CbGpPWpGaD
Loxapine—HTR7—Signaling by GPCR—DRD2—nicotine dependence	5.28e-05	0.000281	CbGpPWpGaD
Loxapine—CHRM5—GPCR downstream signaling—DRD2—nicotine dependence	5.25e-05	0.00028	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—AKR1B10—nicotine dependence	5.25e-05	0.00028	CbGpPWpGaD
Loxapine—HRH4—Signaling Pathways—DRD2—nicotine dependence	5.25e-05	0.000279	CbGpPWpGaD
Loxapine—HTR1D—Signaling by GPCR—DRD2—nicotine dependence	5.24e-05	0.000279	CbGpPWpGaD
Loxapine—ADRA2C—Signaling by GPCR—OPRM1—nicotine dependence	5.23e-05	0.000278	CbGpPWpGaD
Loxapine—DRD2—GPCR downstream signaling—OPRM1—nicotine dependence	5.23e-05	0.000278	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—AKR1B10—nicotine dependence	5.22e-05	0.000278	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—FGD1—nicotine dependence	5.22e-05	0.000278	CbGpPWpGaD
Loxapine—ADRA1B—Signaling by GPCR—OPRM1—nicotine dependence	5.15e-05	0.000274	CbGpPWpGaD
Loxapine—HTR2A—GPCR downstream signaling—OPRM1—nicotine dependence	5.14e-05	0.000274	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—FGD1—nicotine dependence	5.14e-05	0.000273	CbGpPWpGaD
Loxapine—HRH1—GPCR downstream signaling—OPRM1—nicotine dependence	5.13e-05	0.000273	CbGpPWpGaD
Loxapine—HTR1B—Signaling by GPCR—DRD2—nicotine dependence	5.13e-05	0.000273	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—FGD1—nicotine dependence	5.13e-05	0.000273	CbGpPWpGaD
Loxapine—CHRM1—GPCR downstream signaling—OPRM1—nicotine dependence	5.12e-05	0.000272	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—FGD1—nicotine dependence	5.11e-05	0.000272	CbGpPWpGaD
Loxapine—CHRM3—GPCR downstream signaling—OPRM1—nicotine dependence	5.1e-05	0.000271	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—FGD1—nicotine dependence	5.09e-05	0.000271	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—AKR1B10—nicotine dependence	5.08e-05	0.000271	CbGpPWpGaD
Loxapine—CHRM2—GPCR downstream signaling—OPRM1—nicotine dependence	5.05e-05	0.000269	CbGpPWpGaD
Loxapine—DRD4—Signaling by GPCR—DRD2—nicotine dependence	5.05e-05	0.000269	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—FGD1—nicotine dependence	5.04e-05	0.000268	CbGpPWpGaD
Loxapine—ADRA1A—GPCR downstream signaling—OPRM1—nicotine dependence	5.04e-05	0.000268	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—FGD1—nicotine dependence	5.03e-05	0.000268	CbGpPWpGaD
Loxapine—DRD1—GPCR downstream signaling—DRD2—nicotine dependence	5.01e-05	0.000266	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—AKR1B10—nicotine dependence	5e-05	0.000266	CbGpPWpGaD
Loxapine—CHRM3—Metabolism—CYP2A7—nicotine dependence	5e-05	0.000266	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—WASF2—nicotine dependence	5e-05	0.000266	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—WASF2—nicotine dependence	4.99e-05	0.000266	CbGpPWpGaD
Loxapine—CHRM4—Signaling by GPCR—DRD2—nicotine dependence	4.98e-05	0.000265	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—WASF2—nicotine dependence	4.96e-05	0.000264	CbGpPWpGaD
Loxapine—DRD3—GPCR downstream signaling—DRD2—nicotine dependence	4.94e-05	0.000263	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—WASF2—nicotine dependence	4.86e-05	0.000259	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—WASF1—nicotine dependence	4.79e-05	0.000255	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—WASF1—nicotine dependence	4.79e-05	0.000255	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—WASF2—nicotine dependence	4.78e-05	0.000254	CbGpPWpGaD
Loxapine—CHRM5—Signaling by GPCR—DRD2—nicotine dependence	4.77e-05	0.000254	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—WASF1—nicotine dependence	4.76e-05	0.000253	CbGpPWpGaD
Loxapine—DRD2—Signaling by GPCR—OPRM1—nicotine dependence	4.75e-05	0.000253	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—WASF2—nicotine dependence	4.72e-05	0.000251	CbGpPWpGaD
Loxapine—ADRA2A—GPCR downstream signaling—OPRM1—nicotine dependence	4.68e-05	0.000249	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—FGD1—nicotine dependence	4.67e-05	0.000249	CbGpPWpGaD
Loxapine—HTR2A—Signaling by GPCR—OPRM1—nicotine dependence	4.67e-05	0.000249	CbGpPWpGaD
Loxapine—HRH1—Signaling by GPCR—OPRM1—nicotine dependence	4.66e-05	0.000248	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—WASF1—nicotine dependence	4.66e-05	0.000248	CbGpPWpGaD
Loxapine—CHRM1—Signaling by GPCR—OPRM1—nicotine dependence	4.65e-05	0.000247	CbGpPWpGaD
Loxapine—CHRM3—Signaling by GPCR—OPRM1—nicotine dependence	4.63e-05	0.000247	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—AKR1B10—nicotine dependence	4.61e-05	0.000245	CbGpPWpGaD
Loxapine—ADRA2A—Metabolism—CYP2A7—nicotine dependence	4.59e-05	0.000244	CbGpPWpGaD
Loxapine—CHRM2—Signaling by GPCR—OPRM1—nicotine dependence	4.59e-05	0.000244	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—WASF1—nicotine dependence	4.58e-05	0.000244	CbGpPWpGaD
Loxapine—ADRA1A—Signaling by GPCR—OPRM1—nicotine dependence	4.57e-05	0.000243	CbGpPWpGaD
Loxapine—HTR1E—Signaling Pathways—DRD2—nicotine dependence	4.57e-05	0.000243	CbGpPWpGaD
Loxapine—DRD1—Signaling by GPCR—DRD2—nicotine dependence	4.55e-05	0.000242	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—AKR1B10—nicotine dependence	4.54e-05	0.000242	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—AKR1B10—nicotine dependence	4.53e-05	0.000241	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—WASF1—nicotine dependence	4.52e-05	0.000241	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—WASF2—nicotine dependence	4.52e-05	0.00024	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—AKR1B10—nicotine dependence	4.51e-05	0.00024	CbGpPWpGaD
Loxapine—ADRB1—GPCR downstream signaling—DRD2—nicotine dependence	4.5e-05	0.00024	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—AKR1B10—nicotine dependence	4.5e-05	0.000239	CbGpPWpGaD
Loxapine—DRD3—Signaling by GPCR—DRD2—nicotine dependence	4.49e-05	0.000239	CbGpPWpGaD
Loxapine—ADRA2B—GPCR downstream signaling—DRD2—nicotine dependence	4.46e-05	0.000237	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—AKR1B10—nicotine dependence	4.45e-05	0.000237	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—AKR1B10—nicotine dependence	4.44e-05	0.000236	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—WASF1—nicotine dependence	4.33e-05	0.00023	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—OPRM1—nicotine dependence	4.31e-05	0.00023	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—OPRM1—nicotine dependence	4.31e-05	0.000229	CbGpPWpGaD
Loxapine—HTR1A—GPCR downstream signaling—DRD2—nicotine dependence	4.3e-05	0.000229	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—WASF2—nicotine dependence	4.3e-05	0.000229	CbGpPWpGaD
Loxapine—HTR2C—GPCR downstream signaling—DRD2—nicotine dependence	4.28e-05	0.000228	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—OPRM1—nicotine dependence	4.28e-05	0.000228	CbGpPWpGaD
Loxapine—ADRA2A—Signaling by GPCR—OPRM1—nicotine dependence	4.25e-05	0.000226	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—WASF2—nicotine dependence	4.25e-05	0.000226	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—OPRM1—nicotine dependence	4.19e-05	0.000223	CbGpPWpGaD
Loxapine—ADRA2C—GPCR downstream signaling—DRD2—nicotine dependence	4.17e-05	0.000222	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—AKR1B10—nicotine dependence	4.13e-05	0.00022	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—OPRM1—nicotine dependence	4.13e-05	0.00022	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—WASF1—nicotine dependence	4.13e-05	0.00022	CbGpPWpGaD
Loxapine—ADRA1B—GPCR downstream signaling—DRD2—nicotine dependence	4.1e-05	0.000218	CbGpPWpGaD
Loxapine—ADRB1—Signaling by GPCR—DRD2—nicotine dependence	4.09e-05	0.000218	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—OPRM1—nicotine dependence	4.07e-05	0.000217	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—WASF1—nicotine dependence	4.07e-05	0.000217	CbGpPWpGaD
Loxapine—HRH2—Signaling Pathways—DRD2—nicotine dependence	4.07e-05	0.000217	CbGpPWpGaD
Loxapine—ADRA2B—Signaling by GPCR—DRD2—nicotine dependence	4.05e-05	0.000216	CbGpPWpGaD
Loxapine—DRD5—Signaling Pathways—DRD2—nicotine dependence	4.04e-05	0.000215	CbGpPWpGaD
Loxapine—HTR1A—Signaling by GPCR—DRD2—nicotine dependence	3.91e-05	0.000208	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—OPRM1—nicotine dependence	3.9e-05	0.000207	CbGpPWpGaD
Loxapine—HTR2C—Signaling by GPCR—DRD2—nicotine dependence	3.89e-05	0.000207	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—WASF2—nicotine dependence	3.87e-05	0.000206	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—WASF2—nicotine dependence	3.83e-05	0.000204	CbGpPWpGaD
Loxapine—ADRA2C—Signaling by GPCR—DRD2—nicotine dependence	3.78e-05	0.000201	CbGpPWpGaD
Loxapine—ADRA1B—Signaling by GPCR—DRD2—nicotine dependence	3.72e-05	0.000198	CbGpPWpGaD
Loxapine—HTR2A—GPCR downstream signaling—DRD2—nicotine dependence	3.72e-05	0.000198	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—OPRM1—nicotine dependence	3.71e-05	0.000198	CbGpPWpGaD
Loxapine—HRH1—GPCR downstream signaling—DRD2—nicotine dependence	3.71e-05	0.000198	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—WASF1—nicotine dependence	3.71e-05	0.000197	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—WASF2—nicotine dependence	3.7e-05	0.000197	CbGpPWpGaD
Loxapine—CHRM1—GPCR downstream signaling—DRD2—nicotine dependence	3.7e-05	0.000197	CbGpPWpGaD
Loxapine—CHRM3—GPCR downstream signaling—DRD2—nicotine dependence	3.69e-05	0.000196	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—WASF2—nicotine dependence	3.68e-05	0.000196	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—WASF1—nicotine dependence	3.67e-05	0.000196	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—OPRM1—nicotine dependence	3.66e-05	0.000195	CbGpPWpGaD
Loxapine—CHRM2—GPCR downstream signaling—DRD2—nicotine dependence	3.65e-05	0.000194	CbGpPWpGaD
Loxapine—ADRA1A—GPCR downstream signaling—DRD2—nicotine dependence	3.64e-05	0.000194	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—WASF2—nicotine dependence	3.58e-05	0.000191	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—WASF1—nicotine dependence	3.55e-05	0.000189	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—WASF1—nicotine dependence	3.53e-05	0.000188	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—WASF2—nicotine dependence	3.52e-05	0.000188	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—WASF1—nicotine dependence	3.43e-05	0.000183	CbGpPWpGaD
Loxapine—ADRA2A—GPCR downstream signaling—DRD2—nicotine dependence	3.38e-05	0.00018	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—WASF1—nicotine dependence	3.38e-05	0.00018	CbGpPWpGaD
Loxapine—HTR2A—Signaling by GPCR—DRD2—nicotine dependence	3.38e-05	0.00018	CbGpPWpGaD
Loxapine—HRH1—Signaling by GPCR—DRD2—nicotine dependence	3.37e-05	0.000179	CbGpPWpGaD
Loxapine—CHRM1—Signaling by GPCR—DRD2—nicotine dependence	3.36e-05	0.000179	CbGpPWpGaD
Loxapine—CHRM3—Signaling by GPCR—DRD2—nicotine dependence	3.35e-05	0.000178	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—OPRM1—nicotine dependence	3.34e-05	0.000178	CbGpPWpGaD
Loxapine—CHRM2—Signaling by GPCR—DRD2—nicotine dependence	3.32e-05	0.000177	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—OPRM1—nicotine dependence	3.31e-05	0.000176	CbGpPWpGaD
Loxapine—ADRA1A—Signaling by GPCR—DRD2—nicotine dependence	3.31e-05	0.000176	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—WASF2—nicotine dependence	3.25e-05	0.000173	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—WASF2—nicotine dependence	3.2e-05	0.00017	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—OPRM1—nicotine dependence	3.19e-05	0.00017	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—WASF2—nicotine dependence	3.19e-05	0.00017	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—WASF2—nicotine dependence	3.18e-05	0.000169	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—OPRM1—nicotine dependence	3.18e-05	0.000169	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—WASF2—nicotine dependence	3.17e-05	0.000169	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—WASF2—nicotine dependence	3.14e-05	0.000167	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—WASF2—nicotine dependence	3.13e-05	0.000167	CbGpPWpGaD
Loxapine—HTR6—Signaling Pathways—DRD2—nicotine dependence	3.12e-05	0.000166	CbGpPWpGaD
Loxapine—HTR7—Signaling Pathways—DRD2—nicotine dependence	3.12e-05	0.000166	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—WASF1—nicotine dependence	3.11e-05	0.000166	CbGpPWpGaD
Loxapine—HTR1D—Signaling Pathways—DRD2—nicotine dependence	3.1e-05	0.000165	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—OPRM1—nicotine dependence	3.09e-05	0.000165	CbGpPWpGaD
Loxapine—ADRA2A—Signaling by GPCR—DRD2—nicotine dependence	3.07e-05	0.000164	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—WASF1—nicotine dependence	3.06e-05	0.000163	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—WASF1—nicotine dependence	3.06e-05	0.000163	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—WASF1—nicotine dependence	3.05e-05	0.000162	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—OPRM1—nicotine dependence	3.04e-05	0.000162	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—WASF1—nicotine dependence	3.04e-05	0.000162	CbGpPWpGaD
Loxapine—HTR1B—Signaling Pathways—DRD2—nicotine dependence	3.03e-05	0.000161	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—WASF1—nicotine dependence	3.01e-05	0.00016	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—WASF1—nicotine dependence	3e-05	0.00016	CbGpPWpGaD
Loxapine—DRD4—Signaling Pathways—DRD2—nicotine dependence	2.98e-05	0.000159	CbGpPWpGaD
Loxapine—CHRM4—Signaling Pathways—DRD2—nicotine dependence	2.94e-05	0.000157	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—WASF2—nicotine dependence	2.91e-05	0.000155	CbGpPWpGaD
Loxapine—CHRM5—Signaling Pathways—DRD2—nicotine dependence	2.82e-05	0.00015	CbGpPWpGaD
Loxapine—DRD2—Signaling Pathways—OPRM1—nicotine dependence	2.8e-05	0.000149	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—WASF1—nicotine dependence	2.79e-05	0.000148	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—OPRM1—nicotine dependence	2.76e-05	0.000147	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—OPRM1—nicotine dependence	2.75e-05	0.000147	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—OPRM1—nicotine dependence	2.74e-05	0.000146	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—OPRM1—nicotine dependence	2.74e-05	0.000146	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—OPRM1—nicotine dependence	2.71e-05	0.000144	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—OPRM1—nicotine dependence	2.7e-05	0.000144	CbGpPWpGaD
Loxapine—DRD1—Signaling Pathways—DRD2—nicotine dependence	2.69e-05	0.000143	CbGpPWpGaD
Loxapine—DRD3—Signaling Pathways—DRD2—nicotine dependence	2.65e-05	0.000141	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—OPRM1—nicotine dependence	2.51e-05	0.000134	CbGpPWpGaD
Loxapine—ADRB1—Signaling Pathways—DRD2—nicotine dependence	2.41e-05	0.000129	CbGpPWpGaD
Loxapine—ADRA2B—Signaling Pathways—DRD2—nicotine dependence	2.39e-05	0.000127	CbGpPWpGaD
Loxapine—HTR1A—Signaling Pathways—DRD2—nicotine dependence	2.31e-05	0.000123	CbGpPWpGaD
Loxapine—HTR2C—Signaling Pathways—DRD2—nicotine dependence	2.3e-05	0.000122	CbGpPWpGaD
Loxapine—ADRA2C—Signaling Pathways—DRD2—nicotine dependence	2.23e-05	0.000119	CbGpPWpGaD
Loxapine—ADRA1B—Signaling Pathways—DRD2—nicotine dependence	2.2e-05	0.000117	CbGpPWpGaD
Loxapine—HTR2A—Signaling Pathways—DRD2—nicotine dependence	1.99e-05	0.000106	CbGpPWpGaD
Loxapine—HRH1—Signaling Pathways—DRD2—nicotine dependence	1.99e-05	0.000106	CbGpPWpGaD
Loxapine—CHRM1—Signaling Pathways—DRD2—nicotine dependence	1.98e-05	0.000106	CbGpPWpGaD
Loxapine—CHRM3—Signaling Pathways—DRD2—nicotine dependence	1.98e-05	0.000105	CbGpPWpGaD
Loxapine—CHRM2—Signaling Pathways—DRD2—nicotine dependence	1.96e-05	0.000104	CbGpPWpGaD
Loxapine—ADRA1A—Signaling Pathways—DRD2—nicotine dependence	1.95e-05	0.000104	CbGpPWpGaD
Loxapine—ADRA2A—Signaling Pathways—DRD2—nicotine dependence	1.81e-05	9.66e-05	CbGpPWpGaD
